Gemphire Announces Top-Line Data from Familial Partial Lipodystrophy (FPLD) Phase 2a Proof-of-Concept NAFLD/NASH Clinical Trial

Ads

You May Also Like

AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer

ALBANY, N.Y., July 25, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of ...

Reata Pharmaceuticals, Inc. Appoints David Chapman as Vice President, Marketing

IRVING, Texas, March 24, 2017 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (NASDAQ:RETA) (“Reata” or the ...

Aduro Biotech to Present at Two Investor Conferences in March

BERKELEY, Calif., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced ...